SEC Form 4 · accession 0000899243-18-018747
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Semigran
Officer — Chief Medical Officer
Period of report
Jun 28, 2018
Accepted (ET)
Jun 29, 2018 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.95 | Jun 28, 2018 | A | 6,250 | A | Jun 28, 2018 | Nov 30, 2026 | Common Stock | 6,250 | 6,250 | D |
Explanation of responses
- F1On December 1, 2016, the Reporting Person was granted an option to purchase 25,000 shares of Common Stock under the issuer's 2015 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On June 28, 2018, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,250 of the shares underlying such option.
Remarks
Exhibit 24.1 - Power of Attorney